Showing results (91-100 of 114) with videos related to
Sort By:
Pageof 12
Iscience|October 27, 2019
RARβ Agonist Drug (C286) Demonstrates Efficacy in a Pre-clinical Neuropathic Pain Model Restoring Multiple Pathways via DNA Repair MechanismsMaria B Goncalves, Julien Moehlin, Earl Clarke, et al.Prostate Cancer and Prostatic Diseases|December 9, 2017
Patient-reported quality of life progression in men with prostate cancer following primary cryotherapy, cyberknife, or active holistic surveillanceGlenn T Werneburg, Michael Kongnyuy, Daniel M Halpern, et al.The Journal of Infectious Diseases|June 5, 2008
Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndromeIrving Nachamkin, Sean V Shadomy, Anthony P Moran, et al.AIDS Research and Human Retroviruses|September 16, 1998
Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protectionR Stebbings, J Stott, N Almond, et al.Anaesthesia|August 2, 2023
Postoperative systemic inflammation after major abdominal surgery: patient-centred outcomesC R Bain, P S Myles, C Martin, et al.British Journal of Clinical Pharmacology|July 15, 2023
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamic results of KCL-286, a novel retinoic acid receptor-β agonist for treatment of spinal cord injury, in male healthy participantsMaria B Goncalves, Tim Mant, Jörg Täubel, et al.Urology|December 27, 2017
Effects of Focal vs Total Cryotherapy and Minimum Tumor Temperature on Patient-reported Quality of Life Compared With Active Surveillance in Patients With Prostate CancerGlenn T Werneburg, Michael Kongnyuy, Daniel M Halpern, et al.Thrombosis Research|October 24, 2001
Antiplatelet and antithrombotic activity of RWJ-53308, a novel orally active glycoprotein IIb/IIIa antagonistB P Damiano, J A Mitchell, E Giardino, et al.Annals of Surgical Oncology|September 11, 2014
Coupling of prostate and thyroid cancer diagnoses in the United StatesJeffrey J Tomaszewski, Robert G Uzzo, Brian Egleston, et al.Urologic Oncology|April 16, 2017
Predictors of biochemical recurrence after primary focal cryosurgery (hemiablation) for localized prostate cancer: A multi-institutional analytic comparison of Phoenix and Stuttgart criteriaMichael Kongnyuy, Michael J Lipsky, Shahidul Islam, et al.Pageof 12